David Lim
@davidlim.bsky.social
Health reporter @POLITICO covering Covid-19 and the FDA. Prescription Pulse co-author.
The goal, some say, is to target advisers with perceived conflicts interest.
Comes as CDC's ACIP meeting next week is postponed.
Will be interesting to watch Sen. Bill Cassidy's reaction, who said he was assured ACIP will be maintained without changes before voting to confirm Kennedy.
Comes as CDC's ACIP meeting next week is postponed.
Will be interesting to watch Sen. Bill Cassidy's reaction, who said he was assured ACIP will be maintained without changes before voting to confirm Kennedy.
February 20, 2025 at 7:23 PM
The goal, some say, is to target advisers with perceived conflicts interest.
Comes as CDC's ACIP meeting next week is postponed.
Will be interesting to watch Sen. Bill Cassidy's reaction, who said he was assured ACIP will be maintained without changes before voting to confirm Kennedy.
Comes as CDC's ACIP meeting next week is postponed.
Will be interesting to watch Sen. Bill Cassidy's reaction, who said he was assured ACIP will be maintained without changes before voting to confirm Kennedy.
Reposted by David Lim
when you look at the net cost GLP1s won’t be my most expensive drug by far, Kinsley said, most expensive will be Dupixent, don't see that drug on the front page he said.
November 13, 2024 at 2:58 PM
when you look at the net cost GLP1s won’t be my most expensive drug by far, Kinsley said, most expensive will be Dupixent, don't see that drug on the front page he said.